Uric acid as a prognostic factor and critical marker of COVID-19

Abstract The purpose of this study is to explore whether uric acid (UA) can independently act as a prognostic factor and critical marker of the 2019 novel corona virus disease (COVID-19). A multicenter, retrospective, and observational study including 540 patients with confirmed COVID-19 was carried...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gang Li, Xia Wu, Chen-liang Zhou, Ye-ming Wang, Bin Song, Xiao-bin Cheng, Qiu-fen Dong, Liu-lin Wang, Sha-sha You, Yuan-ming Ba
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a8e8859d800d4fcea4e7072829e594b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a8e8859d800d4fcea4e7072829e594b2
record_format dspace
spelling oai:doaj.org-article:a8e8859d800d4fcea4e7072829e594b22021-12-02T18:03:06ZUric acid as a prognostic factor and critical marker of COVID-1910.1038/s41598-021-96983-42045-2322https://doaj.org/article/a8e8859d800d4fcea4e7072829e594b22021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96983-4https://doaj.org/toc/2045-2322Abstract The purpose of this study is to explore whether uric acid (UA) can independently act as a prognostic factor and critical marker of the 2019 novel corona virus disease (COVID-19). A multicenter, retrospective, and observational study including 540 patients with confirmed COVID-19 was carried out at four designated hospitals in Wuhan. Demographic, clinical, laboratory data were collected and analyzed. The primary end point was in-hospital death of patients with COVID-19. The concentration of admission UA (adUA) and the lowest concentration of uric acid during hospitalization (lowUA) in the dead patients were significantly lower than those in the survivors. Multivariate logistic regression analysis showed the concentration of lowUA (OR 0.986, 95% CI 0.980–0.992, p < 0.001) was able to independently predict the risk of in-hospital death. The mean survival time in the low-level group of lowUA was significantly lower than other groups. When lowUA was ≤ 166 µmol/L, the sensitivity and specificity in predicting hospital short-term mortality were 76.9%, (95% CI 68.5–85.1%) and 74.9% (95% CI 70.3–78.9%). This retrospective study determined that the lowest concentration of UA during hospitalization can be used as a prognostic indicator and a marker of disease severity in severe patients with COVID-19.Gang LiXia WuChen-liang ZhouYe-ming WangBin SongXiao-bin ChengQiu-fen DongLiu-lin WangSha-sha YouYuan-ming BaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gang Li
Xia Wu
Chen-liang Zhou
Ye-ming Wang
Bin Song
Xiao-bin Cheng
Qiu-fen Dong
Liu-lin Wang
Sha-sha You
Yuan-ming Ba
Uric acid as a prognostic factor and critical marker of COVID-19
description Abstract The purpose of this study is to explore whether uric acid (UA) can independently act as a prognostic factor and critical marker of the 2019 novel corona virus disease (COVID-19). A multicenter, retrospective, and observational study including 540 patients with confirmed COVID-19 was carried out at four designated hospitals in Wuhan. Demographic, clinical, laboratory data were collected and analyzed. The primary end point was in-hospital death of patients with COVID-19. The concentration of admission UA (adUA) and the lowest concentration of uric acid during hospitalization (lowUA) in the dead patients were significantly lower than those in the survivors. Multivariate logistic regression analysis showed the concentration of lowUA (OR 0.986, 95% CI 0.980–0.992, p < 0.001) was able to independently predict the risk of in-hospital death. The mean survival time in the low-level group of lowUA was significantly lower than other groups. When lowUA was ≤ 166 µmol/L, the sensitivity and specificity in predicting hospital short-term mortality were 76.9%, (95% CI 68.5–85.1%) and 74.9% (95% CI 70.3–78.9%). This retrospective study determined that the lowest concentration of UA during hospitalization can be used as a prognostic indicator and a marker of disease severity in severe patients with COVID-19.
format article
author Gang Li
Xia Wu
Chen-liang Zhou
Ye-ming Wang
Bin Song
Xiao-bin Cheng
Qiu-fen Dong
Liu-lin Wang
Sha-sha You
Yuan-ming Ba
author_facet Gang Li
Xia Wu
Chen-liang Zhou
Ye-ming Wang
Bin Song
Xiao-bin Cheng
Qiu-fen Dong
Liu-lin Wang
Sha-sha You
Yuan-ming Ba
author_sort Gang Li
title Uric acid as a prognostic factor and critical marker of COVID-19
title_short Uric acid as a prognostic factor and critical marker of COVID-19
title_full Uric acid as a prognostic factor and critical marker of COVID-19
title_fullStr Uric acid as a prognostic factor and critical marker of COVID-19
title_full_unstemmed Uric acid as a prognostic factor and critical marker of COVID-19
title_sort uric acid as a prognostic factor and critical marker of covid-19
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a8e8859d800d4fcea4e7072829e594b2
work_keys_str_mv AT gangli uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT xiawu uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT chenliangzhou uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT yemingwang uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT binsong uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT xiaobincheng uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT qiufendong uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT liulinwang uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT shashayou uricacidasaprognosticfactorandcriticalmarkerofcovid19
AT yuanmingba uricacidasaprognosticfactorandcriticalmarkerofcovid19
_version_ 1718378828648153088